Novel and Emerging Targeted Therapies of Colorectal Cancer

被引：4
|
作者：
Finnberg, Niklas [1 ,2 ]
Gokare, Prashanth
El-Deiry, Wafik S.
机构：
[1] Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
来源：
CURRENT CLINICAL PHARMACOLOGY | 2015年 / 10卷 / 04期
关键词：
Clinical; colorectal cancer; DPYD; RAS; targeted therapy; TRAIL;
D O I：
10.2174/1574884710666151020095911
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The survival rate of patients with colorectal cancer (CRC) is steadily increasing over the past decade. However, CRC continue to be one of the leading causes of cancer-related fatality in the United States. Current targeted strategies offer limited clinical benefits and the overall survival rate for CRC remains low. Improved understanding of the molecular changes associated with CRC that control growth factor signaling and evasion of cell death allow for the development of improved targeted therapy. This review aims to discuss some of the emerging therapies aimed to target CRC.
引用
收藏
页码：279 / 298
页数：20
相关论文
共 50 条
  • [31] Combining chemotherapy and targeted therapies in metastatic colorectal cancer
    Rodriguez, J.
    Zarate, R.
    Bandres, E.
    Viudez, A.
    Chopitea, A.
    Garcia-Foncillas, I.
    Gil-Bazo, I.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (44) : 5867 - 5876
  • [32] Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
    Jones, Jeremy C.
    Ciombor, Kristen K.
    Wu, Christina
    Bekaii-Saab, Tanios S.
    Strickler, John
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 654 - 660
  • [33] Progress of research on molecular targeted therapies for colorectal cancer
    Huang, Shilin
    Ye, Jiazhou
    Gao, Xing
    Huang, Xi
    Huang, Julu
    Lu, Lu
    Lu, Cheng
    Li, Yongqiang
    Luo, Min
    Xie, Mingzhi
    Lin, Yan
    Liang, Rong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Tailoring treatment with targeted therapies for advanced colorectal cancer
    Dawson, L. K.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (01): : 37 - 38
  • [35] Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies
    Gould, Harry J., III
    Paul, Dennis
    BIOMEDICINES, 2022, 10 (04)
  • [36] Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
    Jiang, Huafeng
    Zhou, Senjun
    Li, Gang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Novel targeted therapies for advanced esophageal cancer
    Lin, C.-C.
    Papadopoulos, K. P.
    DISEASES OF THE ESOPHAGUS, 2007, 20 (05) : 365 - 371
  • [38] Novel targeted therapies in head and neck cancer
    Ferreira, Mariana B. A.
    Lima, Joao Paulo S. N.
    Cohen, Ezra E. W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (03) : 281 - 295
  • [39] Novel Targeted Therapies in Inflammatory Breast Cancer
    Cristofanilli, Massimo
    CANCER, 2010, 116 (11) : 2837 - 2839
  • [40] Novel targeted therapies for the treatment of penile cancer
    Agarwal, Gautum
    Gupta, Shilpa
    Spiess, Philippe E.
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (08) : 959 - 968
12345